2015
DOI: 10.1186/s12985-015-0383-4
|View full text |Cite
|
Sign up to set email alerts
|

Interferon lambda inhibits dengue virus replication in epithelial cells

Abstract: BackgroundIn viral disease, infection is controlled at the cellular level by type I interferon (IFN-I), but dengue virus (DENV) has the ability to inhibit this response. Type III interferon, also known as lambda IFN (IFN-III or IFN-λ), is a complementary pathway to the antiviral response by IFN-I. This work analyzed the IFN-λ (IFN-III) mediated antiviral response against DENV serotype 2 (DENV-2) infection.MethodsDengue fever patients were sampled to determine their IFN-λ levels by ELISA. To study the IFN-λ res… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

5
47
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 52 publications
(52 citation statements)
references
References 39 publications
(52 reference statements)
5
47
0
Order By: Relevance
“…Among the four members of human IFN-L, IFN-L1 and IFN-L3 are studied most and show some differences in their antiviral activities (Dellgren et al, 2009;Lazear et al, 2015;review). Previous studies have shown that human IFN-L3 has the highest antiviral activity in an in vitro model of encephalomyocarditis viral infection (Palma-Ocampo et al, 2015). This finding is consistent with our results comparing the anti-PEDV activity of rpIFN-L1 and L3, as we found that rpIFN-L3 exhibited more anti-PEDV activity at lower concentrations (from 100 ng/ml to 10 ng/ml) than rpIFN-L1 in IPEC-J2 cells (Figs.…”
Section: Discussionsupporting
confidence: 93%
“…Among the four members of human IFN-L, IFN-L1 and IFN-L3 are studied most and show some differences in their antiviral activities (Dellgren et al, 2009;Lazear et al, 2015;review). Previous studies have shown that human IFN-L3 has the highest antiviral activity in an in vitro model of encephalomyocarditis viral infection (Palma-Ocampo et al, 2015). This finding is consistent with our results comparing the anti-PEDV activity of rpIFN-L1 and L3, as we found that rpIFN-L3 exhibited more anti-PEDV activity at lower concentrations (from 100 ng/ml to 10 ng/ml) than rpIFN-L1 in IPEC-J2 cells (Figs.…”
Section: Discussionsupporting
confidence: 93%
“…In our study, IFN-3 restricts PEDV infection more efficiently than does IFN-1 (Fig. 2), which is consistent with the previously reported finding that IFN-3 exhibits more potent antiviral activity than does IFN-1 (44,46). The potent antiviral activities of type III IFNs indicate therapeutic applications of these cytokines to enteric viral infections.…”
Section: Discussionsupporting
confidence: 92%
“…Type-III IFNs have been shown to control a range of clinically important infections such as flu (21, 59), respiratory syncytial virus (60), norovirus (19, 20), rotavirus (61), Zika virus (62), West Nile virus (63) and Dengue (64). Expression of type-III IFNs in cells of epithelial origin was also induced by clinically relevant bacterial pathogens such as S. aureus and L. monocytogenes as well as M. tuberculosis (65).…”
Section: Discussionmentioning
confidence: 99%